NMRA US Equity
Neumora Therapeutics, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1885522 · FY ends Dec 31$1.64
+0.00 (+0.00%)
USD · as of 2026-08-19 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 7.6M |
| % of shares out | 4.1% |
| Days to cover | 11.0 |
| Δ vs 2026-07-15 | -2.1% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 7,622,548 | -2.1% | 692,473 | 11.0 |
| 2026-07-15 | 7,786,397 | +16.5% | 1,029,524 | 7.6 |
| 2026-06-30 | 6,682,749 | +35.9% | 6,013,588 | 1.1 |
| 2026-06-15 | 4,917,298 | -11.9% | 2,262,846 | 2.2 |
| 2026-05-29 | 5,581,263 | +14.0% | 1,109,768 | 5.0 |
| 2026-05-15 | 4,897,401 | +6.4% | 1,648,146 | 3.0 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
